BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...3D Medicines Corp. raised RMB1.5 billion ($224.8 million) in an undisclosed financing round led by CPE...
BioCentury | Jun 10, 2020
Deals

Deals for leading Chinese immuno-oncology companies: Innovent lands Roche as partner; JW raises $100M

...Partners and was one of the architects of BMS’s $74 billion takeout of Celgene Corp. CPE...
BioCentury | May 23, 2020
Product Development

A guide to serum virus neutralization assays

...is used. Cells are added to the mixture and incubated, and scored for cytopathic effect (CPE...
BioCentury | Aug 30, 2018
Tools & Techniques

Master of autism

...the addition of poly(A) tails in the 3’ UTRs of transcripts, dubbed cytoplasmic polyadenylation elements (CPE...
BioCentury | Mar 30, 2018
Company News

Therapure Biopharma spins out Evolve Biologics

...and CFO Gregory Gould. Last September, a JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE...
BioCentury | Sep 8, 2017
Company News

3SBio to acquire Therapure's CDMO business

...A newly formed JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE Funds, the private equity...
...entity under the name ProductsCo. 3SBio will own 51% of the JV and has granted CPE...
BioCentury | Sep 5, 2017
Company News

3SBio to acquire Therapure's CDMO business

...A newly formed JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE Funds, the private equity...
...entity under the name ProductsCo. 3SBio will own 51% of the JV and has granted CPE...
BioCentury | Mar 7, 2011
Company News

CPEX, Footstar deal

...in annual dividends. Testim, which is marketed by Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL, Malvern, Pa.), uses CPE-125...
BioCentury | Feb 24, 2011
Distillery Techniques

Technology: Markers

...CPE) as a metastasis biomarker In vitro mouse and patient sample studies suggest that truncated CPE...
...HCC) and head and neck cancer. Metastatic HCC cell lines had greater levels of truncated CPE...
...lines. In mice injected with highly metastatic HCC cells, small interfering RNA-mediated knockdown of truncated CPE...
BioCentury | Jan 10, 2011
Company News

CPEX, Footstar deal

...CPEX's assets. CPEX's Nasulin intranasal insulin is in Phase II testing for diabetes and its CPE-215...
Items per page:
1 - 10 of 33
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...3D Medicines Corp. raised RMB1.5 billion ($224.8 million) in an undisclosed financing round led by CPE...
BioCentury | Jun 10, 2020
Deals

Deals for leading Chinese immuno-oncology companies: Innovent lands Roche as partner; JW raises $100M

...Partners and was one of the architects of BMS’s $74 billion takeout of Celgene Corp. CPE...
BioCentury | May 23, 2020
Product Development

A guide to serum virus neutralization assays

...is used. Cells are added to the mixture and incubated, and scored for cytopathic effect (CPE...
BioCentury | Aug 30, 2018
Tools & Techniques

Master of autism

...the addition of poly(A) tails in the 3’ UTRs of transcripts, dubbed cytoplasmic polyadenylation elements (CPE...
BioCentury | Mar 30, 2018
Company News

Therapure Biopharma spins out Evolve Biologics

...and CFO Gregory Gould. Last September, a JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE...
BioCentury | Sep 8, 2017
Company News

3SBio to acquire Therapure's CDMO business

...A newly formed JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE Funds, the private equity...
...entity under the name ProductsCo. 3SBio will own 51% of the JV and has granted CPE...
BioCentury | Sep 5, 2017
Company News

3SBio to acquire Therapure's CDMO business

...A newly formed JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE Funds, the private equity...
...entity under the name ProductsCo. 3SBio will own 51% of the JV and has granted CPE...
BioCentury | Mar 7, 2011
Company News

CPEX, Footstar deal

...in annual dividends. Testim, which is marketed by Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL, Malvern, Pa.), uses CPE-125...
BioCentury | Feb 24, 2011
Distillery Techniques

Technology: Markers

...CPE) as a metastasis biomarker In vitro mouse and patient sample studies suggest that truncated CPE...
...HCC) and head and neck cancer. Metastatic HCC cell lines had greater levels of truncated CPE...
...lines. In mice injected with highly metastatic HCC cells, small interfering RNA-mediated knockdown of truncated CPE...
BioCentury | Jan 10, 2011
Company News

CPEX, Footstar deal

...CPEX's assets. CPEX's Nasulin intranasal insulin is in Phase II testing for diabetes and its CPE-215...
Items per page:
1 - 10 of 33